Summaryobjective To document and verify the number of cases of severe acute respiratory syndrome (SARS) during the 2002-2003 epidemic in mainland China.method All existing Chinese SARS data sources were integrated in one final database. This involved removing non-probable and duplicate cases, adding cases at the final stage of the outbreak, and collecting missing information.
Fugitive road dust (FRD) particles
emitted by traffic-generated
turbulence are an important contributor to urban ambient fine particulate
matter (PM2.5). Especially in urban areas of developing
countries, FRD PM2.5 emissions are a serious environmental
threat to air quality and public health. FRD PM2.5 emissions
have been neglected or substantially underestimated in previous study,
resulting in the underestimation of modeling PM concentrations and
estimating their health impacts. This study constructed the FRD PM2.5 emissions inventory in a major inland city in China (Lanzhou)
in 2017 at high-resolution (500 × 500 m2), investigated
the spatiotemporal characteristics of the FRD emissions in different
urban function zones, and quantified their health impacts. The FRD
PM2.5 emission was approximately 1141 ± 71 kg d–1, accounting for 24.6% of total PM2.5 emission
in urban Lanzhou. Spatially, high emissions exceeding 3 × 104 μg m–2 d–1 occurred
over areas with smaller particle sizes, larger traffic intensities,
and more frequent construction activities. The estimated premature
mortality burden induced by FRD PM2.5 exposure was 234.5
deaths in Lanzhou in 2017. Reducing FRD emissions are an important
step forward to protect public health in many developing urban regions.
A versatile Cu-catalyzed cross-coupling reaction to various unsymmetrical disulfanes has been presented, from phthalimide-carried disulfur transfer reagents and commercially available boronic acids under mild and practical conditions. The method features the unprecedented use of phthalimide-carried disulfurating reagents (Harpp reagent) in cross-coupling chemistry and is highlighted by the broad substrate scopes, even applicable for the transfer of aryldisulfur moieties (ArSS−). Notably, the robustness of this methodology is shown by the late-stage modification of bioactive scaffolds of coumarin, estrone, and captopril.
Male circumcision (MC) is reported to reduce human papillomavirus (HPV) prevalence in men. However, the efficacy remains imprecise. The aim of this study was to conduct a systematic review and meta-analysis to assess the relationship between MC and genital HPV infection and genital warts. PUBMED, EMBASE, and Web of Science were searched from inception to March 22, 2015. We identified 30 papers, including a total of 12149 circumcised and 12252 uncircumcised men who were evaluated for the association of circumcision with genital HPV or genital warts. Compared with men who were not circumcised, circumcised men may have had significantly reduced odds of genital HPV prevalence (odds ratio [OR]: 0.68; 95% confidence interval [95% CI]: 0.56–0.82). There was no significant association between MC and genital HPV acquisition of new infections (OR: 0.99; 95% CI: 0.62–1.60), genital HPV clearance (OR: 1.38; 95% CI: 0.96–1.97), and prevalence of genital warts (OR: 1.17; 95% CI: 0.63–2.17). This meta-analysis suggests that circumcision reduces the prevalence of genital HPV infections. However, no clear evidence was found that circumcision was associated with decreased HPV acquisition, increased HPV clearance, or decreased the prevalence of genital warts. More studies are required to evaluate adequately the effect of MC on the acquisition and clearance of HPV infections and prevalence of genital warts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.